Cardiovascular disease is among the health outcomes with growing epidemiological evidence linking PFAS exposure. As the leading cause of death in the United States, cardiovascular disease risk reduction is a high-priority health objective, and PFAS reduction through water filtration represents one modifiable risk factor that can be addressed at the household level.
PFAS and Cholesterol
Some of the most replicated epidemiological findings in PFAS research are associations between PFAS exposure and elevated total cholesterol, LDL cholesterol, and in some studies altered lipid profiles. These associations have been found in cross-sectional and prospective studies across multiple populations and PFAS compounds. Mechanisms under investigation include PFAS effects on liver function (the primary site of cholesterol metabolism) and disruption of nuclear receptors regulating lipid metabolism.
Hypertension and PFAS
More recent research has found associations between PFAS exposure and hypertension — particularly in pregnant women, where gestational hypertension and preeclampsia have been associated with PFAS blood levels. Blood pressure effects in the general adult population are less consistent but represent an ongoing research area given the cardiovascular significance of hypertension control.
Filtration in the Context of Cardiovascular Risk Reduction
For individuals managing cardiovascular risk factors — particularly those with elevated cholesterol or hypertension — reducing all modifiable risk factors is clinically important. Water filtration for PFAS reduction is a low-cost, low-burden intervention that fits naturally within a comprehensive cardiovascular risk management approach. While not a substitute for medication, diet, and exercise in cardiovascular care, filtration provides an incremental risk reduction with no adverse effects — making it a straightforward recommendation for those living in PFAS-affected areas with existing cardiovascular concerns.